References
- Marie I, Hachulla E, Hatron E, Henot M, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors of prognosis. J Ftheumatol 2001;28:2230–7.
- Lakhanpal S, Lie JT, Conn DL, Martin WJ. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46:23–9.
- Gruhn W, Diaz-Buxo J. Cyclosporin treatment of steroid-resistant interstitial pneumonitis associated with dermatomyositis. J Ftheu-matol 1987;14:1045–7.
- Maeda K, Kimura R, Komuta K, Igarashi T. Cyclosporine treat-ment for polymyositis/dermatomyositis. Is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Ftheumatol 1997;26:24–9.
- Matsuda Y, Tomii M, Kashiwazaki S. Fatal pneumomediastinum in dermatomyositis without creatine kinase elevation. Intern Med 1993;32:643–7.
- Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine ki-nase elevation: a poor prognosis sign. Am J Med 1986;80:329–32.
- Bohn A, Peter JP. Polymyositis and dermatomyositis (Parts 1 and 2). N Engl J Med 1975;292:344-7,403–7.
- Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis): presentation of six new cases and review of the literature. J Am Acad Dermatol 1991;24:959–66.
- Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a re-view. J Invest Dermatol 1993;100 Supp1:124S–7S.
- Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K. Pulmo-nary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol 1997;169:83–7.
- Pearson CM. Polymyositis and dermatomyositis. In: McCarty DJ, editor. Arthritis and allied conditions. 9th ed. Philadelphia: Lea and Febiger; 1979. p. 742–61.
- Katzenstein AL, Fiorelli FtF. Nonspecific interstitial pneumonia/ fibrosis: histologic patterns and clinical significance. Am J Surg Pathol 1994;18:136–47.
- Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727–33.
- Toyoshima M, Sato A, Chida K, Hayakawa H, Todate A, Imokawa S, et al. Clinicopathological features of interstitial pneumonia asso-ciated with amyopathic dermatomyositis (in Japanese). Nihon Kokyuki Gakkai Zassi 1997;35:281–7.
- McLoud TC, Carrington CB, Gaensler EA. Diffuse infiltrative lung disease: a new scheme for description. Radiology 1983;149: 353–63.
- Maunder RJ, Pierson DJ, Hudson LD. Subcutaneous and medias-tinal emphysema. Pathophysiology, diagnosis, and management. Arch Intern Med 1984;144:1447–53.
- Kobayashi N, Takizawa H, Sugiyama A, Dohi M, Ishii A, Ohta K, et al. A case of dermatomyositis which rapidly developed to respi-ratory failure in the presence of pneumomediastinum (in Japanese). Jpn J Thorac Dis 1989;27:848–54.
- Cicuttini FM, Fraser KJ. Recurrent pneumomediastinum in adult dermatomyositis. J Ftheumatol 1989;16:384–6.
- Isfer RS, Nakao SK, Cemea SS. Dermatomyositis associated with pneumomediastinum and subcutaneous cellular tissue emphy-sema. Br J Ftheumatol 1994;33:1092.
- Toro Santos FJ, Hernando HV, Montero C, Aparicio MB, Torres Lanzas J, Pombo Feripe F. Chronic pneumomediastinum and sub-cutaneous emphysema: association with dermatomyositis. Respira-tion 1995;62:53–6.
- Satomi K, Michibata T, Ezuka H, Fukuda H, Miyashita T. Recur-rent pneumomediastinum in the course of interstitial pneumonia associated with dermatomyositis (in Japanese). Nihon Kokyuki Gakkai Zassi 1998;36:984–8.
- Bradley JD. Spontaneous pneumomediastinum in adult dermato-myositis. Ann Rheum Dis 1986;45:780–2.
- Singsen BH, Tedford JC, Platzker AC, Hanson V. Spontaneous pneumothorax: a complication of juvenile dermatomyositis. J Pediatr 1978;92:771–4.
- Kono H, Inokuma S, Nakayama H, Suzuki M. Pneumomediasti-num in dermatomyositis association with cutaneous vasculopathy. Ann Rheum Dis 2000;59:372–6.
- Pugh MT, Collins NA, Rai A, Hollinrake K, Coppock JS. A case of adult dermatomyositis treated with cyclosporin A [letter]. Br J Ftheumatol 1992;31:855.
- Hara M, Hariga M, Kashiwazaki S. National-wide surveillance for the treatment with cyclosporin of interstitial pneumonia associated with collagen diseases. Annual Report of the Ministry of Health and Welfare Autoimmune Diseases Research Committee 1997. p. 60–6.
- Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, et al. Corticosteroid-resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Ftheumatol 1999;26:1527–33.
- Shinohara T, Hidaka T, Matsuki Y, Ishizuka T, Takamizawa M, Kawakami M, et al. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclo-phosphamide pulse therapy. Intern Med 1997;36:519–23.
- Al-Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Ftheumatol 1989;16:1592–6.
- Tanaka F, Origuchi T, Migita K, Tominaga M, Kawakami A, Kawabe Y, et al. Successful combined therapy of cyclophospha-mide and cyclosporine for acute exacerbated interstitial pneumo-nia associated with dermatomyositis. Intern Med 2000;39:428–30.
- Yamasaki M, Yamada H, Hama N, Niimi H, Kurihara H, Nakajima Y, et al. Analysis of the prognosis of polymyositis/ dermatomyositis-associated interstitial pneumonia: predictor of a relapse. St Marianna Med J 2000;28:453–9.